EVM
MED icon

Eaton Vance Management’s Medifast MED Stock Holding History

Eaton Vance Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-364
Closed -$76K – 2350
2021
Q4 		$76K Sell
364
-12
-3% -$2.48K ﹤0.01% 1936
2021
Q3 		$0 Sell
376
-6
-2% -$1.48K ﹤0.01% 2418
2021
Q2 		$108K Buy
382
+288
+306% +$78K ﹤0.01% 1872
2021
Q1 		$20K Buy
+94
New +$22.5K ﹤0.01% 2089

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Eaton Vance Management's MED Position: Q1 2022 in Review

Eaton Vance Management sold out of Medifast (MED) in Q1 2022, closing a stake of 364 shares — an estimated $76K sold.

Eaton Vance Management first reported a position in MED in Q1 2021 and held it in 4 quarters. The position peaked at $108K in Q2 2021. 288 funds tracked by Wall St. Rank hold MED as of Q1 2022.

  • Eaton Vance Management reported no remaining Medifast position as of Q1 2022 after selling out during the quarter.
  • Eaton Vance Management sold 364 Medifast shares in Q1 2022, an estimated $76K.
  • Eaton Vance Management first reported a position in Medifast in Q1 2021 and held it in 4 quarters.
  • Eaton Vance Management's Medifast position peaked at $108K in Q2 2021.
  • 288 funds tracked by Wall St. Rank held Medifast as of Q1 2022.

Based on Eaton Vance Management's 13F filing for Q1 2022, filed 16 May 2022.